Testing a rapamycin stent for blocked coronary arteries
Part of Heart & circulation clinical trials.
This study tests a new kind of coronary stent that slowly releases rapamycin to keep an artery open. You may be invited if you have a small number of specific, treatable blockages and can take the required blood-thinning medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old, and you’re able to sign consent
- You have a planned stent procedure for 1–2 new (previously untreated) blockage sites
- The blockage must be in a specific artery area and meet size/shape limits from angiogram pictures
- Your heart pumping strength is not too weak (ejection fraction must be at least 35%) and heart failure is not severe
- You must not have recent heart attack, kidney failure, serious bleeding risk, or certain recent brain bleeds or strokes
- You must be able to take aspirin and clopidogrel (and related medicines) and not be allergic to the stent materials/rapamycin/contrast
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults who have fast, unexplained re-narrowing of a coronary stent, to better understand what causes it and how to monitor it. You may help by allowing the study team to collect medical information over time.
This trial tests a stent that slowly dissolves after opening a blocked heart artery, releasing a drug to prevent reclogging. It may help people with narrowing in one or two spots that are not too hard or twisted.
This trial tests a longer-than-usual drug-coated stent (Orsiro Mission) for treating long blockages in heart arteries. It aims to see if the stent is safe and effective for people with coronary artery disease.
This trial tests a new heart stent called MiStent II to treat narrowed coronary (heart) arteries. It looks at whether the stent is safe and works well for people who need a procedure to restore blood flow.
This study looks at how well doctors can treat multiple blocked heart arteries using a specific drug-eluting stent, aiming to fully open them. It may help patients whose blockage pattern fits the study, but it does not include certain high-risk or special cases.
This study compares how best to place a coronary stent (a small tube to keep an artery open) using modern techniques. It may help improve how safely and effectively stents are delivered in people with certain types of narrowed heart arteries.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.